<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Vet Med Sci</journal-id>
      <journal-id journal-id-type="iso-abbrev">J. Vet. Med. Sci</journal-id>
      <journal-id journal-id-type="publisher-id">JVMS</journal-id>
      <journal-title-group>
        <journal-title>The Journal of Veterinary Medical Science</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0916-7250</issn>
      <issn pub-type="epub">1347-7439</issn>
      <publisher>
        <publisher-name>The Japanese Society of Veterinary Science</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25892536</article-id>
      <article-id pub-id-type="pmc">4591163</article-id>
      <article-id pub-id-type="publisher-id">15-0117</article-id>
      <article-id pub-id-type="doi">10.1292/jvms.15-0117</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Pathology</subject>
          <subj-group>
            <subject>Note</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Pathological features of proteinuric nephropathy resembling Alport syndrome
in a young Pyrenean Mountain dog</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>SUGAHARA</surname>
            <given-names>Go</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>NAITO</surname>
            <given-names>Ichiro</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>MIYAGAWA</surname>
            <given-names>Yuichi</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>KOMIYAMA</surname>
            <given-names>Takaaki</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>TAKEMURA</surname>
            <given-names>Naoyuki</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>KOBAYASHI</surname>
            <given-names>Ryosuke</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>MINESHIGE</surname>
            <given-names>Takayuki</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>KAMIIE</surname>
            <given-names>Junichi</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>SHIROTA</surname>
            <given-names>Kinji</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref rid="cor1" ref-type="corresp">
            <sup>*</sup>
          </xref>
        </contrib>
        <aff id="aff1"><label>1)</label>Laboratory of Veterinary Pathology, School of Veterinary
Medicine, Azabu University, 1&#x2013;17&#x2013;71 Fuchinobe, Chuo-ku, Sagamihara, Kanagawa 252&#x2013;5201,
Japan</aff>
        <aff id="aff2"><label>2)</label>Division of Human Morphology, Okayama University Medical
School, 2&#x2013;5&#x2013;1 Shikata, Kitaku, Okayama 700&#x2013;8558, Japan</aff>
        <aff id="aff3"><label>3)</label>2nd Laboratory of Veterinary Internal Medicine, School of
Veterinary Medicine, Nippon Veterinary and Life Science University, 1&#x2013;7&#x2013;1 Kyonan-cho,
Musashino, Tokyo 180&#x2013;8602, Japan</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1"><label>*</label>Correspondence to: Shirota, K., Laboratory of Veterinary
Pathology, Azabu University, 1&#x2013;17&#x2013;71 Fuchinobe, Chuo-ku, Sagamihara, Kanagawa 252&#x2013;5201,
Japan. e-mail: <email xlink:href="shirota@azabu-u.ac.jp">shirota@azabu-u.ac.jp</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>17</day>
        <month>4</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2015</year>
      </pub-date>
      <volume>77</volume>
      <issue>9</issue>
      <fpage>1175</fpage>
      <lpage>1178</lpage>
      <history>
        <date date-type="received">
          <day>02</day>
          <month>3</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>03</day>
          <month>4</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2015 The Japanese Society of Veterinary Science</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. </license-p>
        </license>
      </permissions>
      <abstract>
        <p>The renal biopsy tissue from a 9-month-old, male Pyrenean Mountain dog with
renal disorder and severe proteinuria was examined. Ultrastructural examination revealed
multilaminar splitting and fragmentation of the glomerular basement membrane (GBM) and
diffuse podocyte foot process effacement. Immunofluorescent staining for &#x3B1;(IV) chains
revealed presence of &#x3B1;5(IV) and complete absence of &#x3B1;3(IV) and &#x3B1;4(IV) chains in the GBM.
Immunohistochemistry also revealed decreased and altered expression of nephrin and podocin
in the glomeruli compared with normal canine glomeruli. These results suggested that the
glomerular disease of the present case might be consistent with canine hereditary
nephropathy resembling human Alport syndrome caused by genetic defect of type IV collagen,
and indicated possible contribution of podocyte injury to severe proteinuria in this
case.</p>
      </abstract>
      <kwd-group>
        <kwd>Alport syndrome</kwd>
        <kwd>canine</kwd>
        <kwd>hereditary nephropathy</kwd>
        <kwd>type IV collagen</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Hereditary nephropathy (HN) resulting from a defect of type IV collagen (collagen IV), a main
component of the glomerular basement membrane (GBM), has been identified in several domestic
dog breeds, and the symptom profile is analogous to human Alport syndrome (AS), except for the
hearing loss and blindness [<xref rid="r11" ref-type="bibr">11</xref>, <xref rid="r14" ref-type="bibr">14</xref>]. Human AS is a genetic disorder caused by an abnormality of collagen IV
and characterized by progressive renal disease, typically involving hematuria, proteinuria,
hearing loss and blindness [<xref rid="r3" ref-type="bibr">3</xref>, <xref rid="r9" ref-type="bibr">9</xref>]. In human and dogs, the disease is diagnosed by presence of
characteristic ultrastructural features of the GBM, immunofluorescence staining (IF) results
using antibodies specific for the &#x3B1;(IV) chain and genetic testing results. In particular, IF
for several &#x3B1;(IV) chains is a most reliable and useful diagnostic method and also can
distinguish the autosomal type from the X-linked form due to the following characteristics of
collagen IV [<xref rid="r14" ref-type="bibr">14</xref>]. Collagen IV has six distinct &#x3B1;(IV)
chains [designated as &#x3B1;1(IV) &#x2212; &#x3B1;6(IV)] encoded by six genes (designated as
<italic>COL4A1</italic> &#x2212; <italic>COL4A6</italic>). Three different heterotrimeric units
(designated as &#x3B1;1/&#x3B1;1/&#x3B1;2, &#x3B1;3/&#x3B1;4/&#x3B1;5 and &#x3B1;5/&#x3B1;5/&#x3B1;6) are formed from the six &#x3B1;(IV) chains [<xref rid="r9" ref-type="bibr">9</xref>], and these heterotrimers have different distributional
features: &#x3B1;1/&#x3B1;1/&#x3B1;2 trimers widely distribute in the basement membrane (BM); &#x3B1;5/&#x3B1;5/&#x3B1;6 trimers
distribute mainly in Bowman&#x2019;s capsule BM and tubular BM; and &#x3B1;3/&#x3B1;4/&#x3B1;5 trimers are limited to
the GBM in the kidney [<xref rid="r9" ref-type="bibr">9</xref>, <xref rid="r14" ref-type="bibr">14</xref>]. Mutations in <italic>COL4A3</italic>, <italic>COL4A4</italic> or
<italic>COL4A5</italic> result in loss of &#x3B1;3/&#x3B1;4/&#x3B1;5 trimers from the GBM, leading to
dysfunction of glomerular filtration. Therefore, it is useful for the diagnosis of human AS
and canine HN to confirm the distribution of several &#x3B1;(IV) chains within renal tissue using
immunostaining.</p>
    <p>The glomerular slit diaphragm (SD) is located between foot processes (FPs) of the podocytes
and plays a critical role in selective filtration together with the GBM. SD-associated
proteins, such as nephrin and podocin, are expressed in FPs and SDs, and altered expression of
these proteins has been described in pathological situations involving podocyte injuries
related to proteinuria in humans and in animal models [<xref rid="r12" ref-type="bibr">12</xref>, <xref rid="r21" ref-type="bibr">21</xref>], including an AS mouse model [<xref rid="r6" ref-type="bibr">6</xref>, <xref rid="r23" ref-type="bibr">23</xref>]. Expression of
these proteins in normal dogs was demonstrated in a previously reported study [<xref rid="r13" ref-type="bibr">13</xref>]; another report described altered expression of these
proteins in several glomerular diseases of dogs [<xref rid="r10" ref-type="bibr">10</xref>];
but it has not, to our knowledge, been described in canine HN. Here, we describe pathological
features of proteinuric nephropathy resembling AS in a young Pyrenean Mountain dog and
demonstrate altered expression of nephrin and podocin in the glomeruli.</p>
    <p>The case was a 9-month-old, male Pyrenean Mountain dog with azotemia (BUN: 59.1
mg/d<italic>l</italic>, creatinine: 2.66 mg/d<italic>l</italic>), hypoalbuminaemia (albumin:
1.8 g/d<italic>l</italic>), proteinuria (urinary protein-to-creatinine ratio: 7.4 when first
seen and 5.4 when biopsy was performed) and occult hematuria. The familial history of the case
was unknown. A renal biopsy specimen was obtained by using a 14-gauge Tru-cut-type needle.
Renal tissue from a healthy 12-month-old, male beagle dog was used for comparison.</p>
    <p>Two-thirds of the biopsy tissue was fixed in 10% neutral-buffered formalin and then embedded
in paraffin wax. Sections (3 <italic>&#xB5;</italic>m) then were stained with hematoxylin and eosin
(HE) and periodic acid-Schiff (PAS) reagents for histological examination. For ultrastructural
examination, the other one-third of the biopsy tissue was fixed in 2.5% glutaraldehyde and
post-fixed in 1% OsO<sub>4</sub>. Fixed specimens were then dehydrated through ascending
grades of alcohol and embedded in epoxy resin. Ultrathin sections were stained with uranyl
acetate and lead citrate and observed using a JEOL 1210 transmission electron microscope
(JEOL, Tokyo, Japan) at 80 kV.</p>
    <p>For IF, rat monoclonal antibodies established in previous studies [<xref rid="r7" ref-type="bibr">7</xref>, <xref rid="r20" ref-type="bibr">20</xref>, <xref rid="r24" ref-type="bibr">24</xref>] were used as following specificity; H11, H22, H31 and H43 recognize,
respectively, the human NC1 domain of the &#x3B1;1(IV), &#x3B1;2(IV), &#x3B1;3(IV) and &#x3B1;4(IV) chains, and H53,
H65 and B66 recognize, respectively, the human helix of the &#x3B1;5(IV), &#x3B1;6(IV) chains and the
bovine helix of the &#x3B1;6(IV) chain. The sections were pretreated by Target Retrieval Solution,
pH 6.1 (Nichirei, Tokyo, Japan) at 100&#xB0;C for 10 min in an autoclave and by collagenase, pH
7.6, 100 U/m<italic>l </italic>(Sigma, St. Louis, MO, U.S.A.; C2674) at 37&#xB0;C for 30 min. As
described in our previous report [<xref rid="r13" ref-type="bibr">13</xref>], nephrin and
podocin were detected by using rabbit anti-human podocin (Sigma) and rabbit anti-canine
nephrin established in our laboratory. The sections were pretreated by Target Retrieval
Solution, pH 9.0 (Nichirei) at 121&#xB0;C for 5 min in an autoclave (nephrin) or by trypsin (Sigma;
T7168) at 37&#xB0;C for 30 min (podocin). The secondary antibodies were fluorescein
isothiocyanate-conjugated goat anti-rat IgG (Cappel, Aurora, OH, U.S.A.) or Alexa Fluor
488-conjugated goat anti-rabbit IgG (Invitrogen, Tokyo, Japan).</p>
    <p>Four exons (exons 3 and 30 of <italic>COL4A4</italic> and exons 9 and 35 of
<italic>COL4A5</italic>) were previously reported as causative gene mutation sites in HN
dogs [<xref rid="r14" ref-type="bibr">14</xref>]. Therefore, these exons were amplified by
polymerase chain reaction (PCR) using genomic DNA from whole blood of the current case.
Sequencing of the amplicons was performed by Dragon GenomicsCenter, TAKARA BIO INC. (Otsu,
Japan).</p>
    <p>Microscopically, only mild irregular thickening of the capillary walls and cystic dilation
with hemorrhage of the Bowman&#x2019;s capsule were observed (<xref ref-type="fig" rid="fig_001">Fig.
1</xref><fig orientation="portrait" fig-type="figure" id="fig_001" position="float"><label>Fig. 1.</label><caption><p>Light microscopic features of the biopsy specimen. Mild and irregular thickening of the
capillary walls is observed (arrowheads). PAS stain. Bar, 30 <italic>&#xB5;</italic>m. Inset:
cystic dilation with hemorrhage of the Bowman&#x2019;s capsule is observed (asterisk). H.E.
stain. Bar, 50 <italic>&#xB5;</italic>m.</p></caption><graphic xlink:href="jvms-77-1175-g001"/></fig>). Mild interstitial inflammation, fibrosis and interstitial foam cells were
observed.</p>
    <p>The ultrastructural appearance of the GBM included distinctive morphological features of HN,
namely, irregular and global thickening of the GBM with multilaminar splitting and
fragmentation of the lamina densa (<xref ref-type="fig" rid="fig_002">Fig. 2</xref><fig orientation="portrait" fig-type="figure" id="fig_002" position="float"><label>Fig. 2.</label><caption><p>Transmission electron microscopic features of the biopsy specimen. The lamina densa of
the GBM is irregularly and globally thickened with multilaminar splitting and
fragmentation (arrows). Severe foot process effacement is also observed (arrowheads).
CL, capillary lumen; US, urinary space; Po, podocyte. TEM. Bar, 2
<italic>&#xB5;</italic>m.</p></caption><graphic xlink:href="jvms-77-1175-g002"/></fig>). Severe FP effacement of the podocytes was also observed.</p>
    <p>By IF, the pattern of labeling for each &#x3B1;(IV) chain in the case was different from that in
the normal dog. The &#x3B1;1(IV) and &#x3B1;2(IV) chains were distributed in all basement membranes (BM)
and mesangial regions in both animals; however, an increased intensity of these chains was
observed in the case (<xref ref-type="fig" rid="fig_003">Fig. 3A and 3B</xref><fig orientation="portrait" fig-type="figure" id="fig_003" position="float"><label>Fig. 3.</label><caption><p>Immunofluorescence for several &#x3B1;(IV) chains in the glomeruli of the case and a normal
dog (respective insets). &#x3B1;1(IV) and &#x3B1;2(IV) chains (A and B, respectively) were increased
in the GBM; &#x3B1;3(IV) and &#x3B1;4(IV) chains (C and D, respectively) were completely absent in
the GBM; &#x3B1;5(IV) and &#x3B1;6(IV) chains (E and F, respectively) were observed in both the GBM
and Bowman&#x2019;s capsule BM. IF. &#xD7;400. Inset: expression pattern of respective &#x3B1;(IV) chains
in the normal glomeruli.</p></caption><graphic xlink:href="jvms-77-1175-g003"/></fig>). Labeling of the &#x3B1;3(IV) and &#x3B1;4(IV) chains in the GBM was completely absent in the case
(<xref ref-type="fig" rid="fig_003">Fig. 3C and 3D</xref>). Although the intensity was
reduced compared with the normal dog, labeling of the &#x3B1;5(IV) chain was observed in the GBM and
Bowman&#x2019;s capsule BM in the case (<xref ref-type="fig" rid="fig_003">Fig. 3E</xref>).
Additionally, labeling of the &#x3B1;6(IV) chain was observed in the GBM of the case, but not in the
normal dog (<xref ref-type="fig" rid="fig_003">Fig. 3F</xref>).</p>
    <p>Expression of nephrin and podocin was in a sharp linear pattern along the GBM in the normal
glomerulus. On the other hand, the nephrin staining pattern was shifted to a cytoplasmic and
granular pattern in the case (<xref ref-type="fig" rid="fig_004">Fig. 4A</xref><fig orientation="portrait" fig-type="figure" id="fig_004" position="float"><label>Fig. 4.</label><caption><p>Immunofluorescence staining for nephrin (A) and podocin (B) in the glomeruli of the
case and a normal dog (respective insets). Expression of both molecules in the case was
decreased, and the staining patterns were shifted from the sharp linear pattern observed
along the glomerular capillary walls of normal glomeruli to a coarse granular pattern.
IF. Bar, 3 <italic>&#xB5;</italic>m.</p></caption><graphic xlink:href="jvms-77-1175-g004"/></fig>). Expression of podocin was decreased and its staining pattern was changed to a
granular pattern, although remaining along the GBM (<xref ref-type="fig" rid="fig_004">Fig.
4B</xref>).</p>
    <p>The 4 previously-reported gene mutations of the &#x3B1;(IV) chains causative of canine HN,
mentioned above, were not detected (data not shown).</p>
    <p>Numerous mutation sites are confirmed in <italic>COL4A3</italic>, <italic>COL4A4</italic> or
<italic>COL4A5</italic> gene in human AS [<xref rid="r1" ref-type="bibr">1</xref>, <xref rid="r18" ref-type="bibr">18</xref>]. They are scattered throughout many exons, and there
are no hotspots, making AS difficult to diagnose using genetic testing. In the current case,
mutation was not detected at any previously-reported mutation sites in HN dogs. However, we
diagnosed this case as HN resembling AS based on the typical ultrastructural findings of GBM
and disappearance of &#x3B1;3(IV) and &#x3B1;4(IV) chains from the renal tissue. Additionally, appearance
of &#x3B1;5(IV) chains in the GBM and Bowman&#x2019;s capsule indicated autosomal type HN, because
<italic>COL4A3</italic> and <italic>COL4A4</italic> are on chromosome 25, and
<italic>COL4A5</italic> and <italic>COL4A6</italic> are on the X chromosome in dogs [<xref rid="r17" ref-type="bibr">17</xref>]. Therefore, in the X-linked type, because a defect of
&#x3B1;5(IV) chains causes loss of &#x3B1;3/&#x3B1;4/&#x3B1;5 and &#x3B1;5/&#x3B1;5/&#x3B1;6 trimers, all &#x3B1;3(IV), &#x3B1;4(IV), &#x3B1;5(IV) and
&#x3B1;6(IV) chains should disappear from both the GBM and Bowman&#x2019;s capsule BM. Although increased
expression of &#x3B1;1/&#x3B1;1/&#x3B1;2 trimers in the glomeruli is commonly observed in human AS and canine
HN, increased expression of &#x3B1;5/&#x3B1;5/&#x3B1;6 trimers was only reported in the autosomal type of canine
HN [<xref rid="r16" ref-type="bibr">16</xref>, <xref rid="r20" ref-type="bibr">20</xref>]. In
a previous study, expression of &#x3B1;5/&#x3B1;5/&#x3B1;6 trimers in the GBM was normally observed in normal
dogs more than about 45 months old, but not in those younger than 30 months [<xref rid="r15" ref-type="bibr">15</xref>], whereas it was not observed in humans regardless of
age [<xref rid="r19" ref-type="bibr">19</xref>, <xref rid="r22" ref-type="bibr">22</xref>].
This characteristic property of normal dogs may relate to the expression of &#x3B1;5/&#x3B1;5/&#x3B1;6 trimers
in young dogs with the autosomal type canine HN.</p>
    <p>In human AS and canine HN, mutations of collagen IV cause GBM abnormalities and subsequent
podocyte injuries lead to massive proteinuria, and finally cause end-stage renal disease. In
general, it is thought that podocyte injury with loss of the SDs is a major cause of marked
albuminuria and nephrotic syndrome [<xref rid="r2" ref-type="bibr">2</xref>, <xref rid="r6" ref-type="bibr">6</xref>]. However, proteinuria in AS, especially in the early
stages of the disease, is thought to be associated with damage to the GBM rather than to
primary loss of the SDs and FP effacement, and it is considered to be a secondary response to
proteinuria and the abnormal GBM [<xref rid="r5" ref-type="bibr">5</xref>, <xref rid="r8" ref-type="bibr">8</xref>]. But, at the same time, it has been indicated that
multiple glomerular cell types participate in the pathogenic process underlying AS progression
and podocyte damage may be a precipitating factor in disease progression [<xref rid="r4" ref-type="bibr">4</xref>, <xref rid="r6" ref-type="bibr">6</xref>, <xref rid="r23" ref-type="bibr">23</xref>]. In the previous reports of canine HN, FP effacement
was noted, but expression of SD-associated proteins was not examined. In this case, massive
proteinuria and also altered expression of these SD-associated proteins were observed,
accompanied by severe FP effacement and GBM abnormality. As in the AS mouse models [<xref rid="r4" ref-type="bibr">4</xref>, <xref rid="r6" ref-type="bibr">6</xref>, <xref rid="r23" ref-type="bibr">23</xref>], the GBM abnormality might be followed by severe
podocyte injury in this case.</p>
    <p>In conclusion, the GBM abnormality caused by genetic defect of collagen IV in canine HN might
associate podocyte injury leading to proteinuria and progress of the disease.</p>
  </body>
  <back>
    <ack>
      <p>This Research was partially supported by a research project grant (2014K05)
awarded by the Azabu University.</p>
    </ack>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Artuso</surname><given-names>R.</given-names></name><name><surname>Fallerini</surname><given-names>C.</given-names></name><name><surname>Dosa</surname><given-names>L.</given-names></name><name><surname>Scionti</surname><given-names>F.</given-names></name><name><surname>Clementi</surname><given-names>M.</given-names></name><name><surname>Garosi</surname><given-names>G.</given-names></name><name><surname>Massella</surname><given-names>L.</given-names></name><name><surname>Epistolato</surname><given-names>M. C.</given-names></name><name><surname>Mancini</surname><given-names>R.</given-names></name><name><surname>Mari</surname><given-names>F.</given-names></name><name><surname>Longo</surname><given-names>I.</given-names></name><name><surname>Ariani</surname><given-names>F.</given-names></name><name><surname>Renieri</surname><given-names>A.</given-names></name><name><surname>Bruttini</surname><given-names>M.</given-names></name></person-group><year>2012</year>. <article-title>Advances in Alport syndrome diagnosis
using next-generation sequencing</article-title>. <source><italic>Eur. J. Hum.
Genet.</italic></source><volume>20</volume>: <fpage>50</fpage>&#x2013;<lpage>57</lpage>. doi:
<pub-id pub-id-type="doi">10.1038/ejhg.2011.164</pub-id><pub-id pub-id-type="pmid">21897443</pub-id></mixed-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Brinkkoetter</surname><given-names>P. T.</given-names></name><name><surname>Ising</surname><given-names>C.</given-names></name><name><surname>Benzing</surname><given-names>T.</given-names></name></person-group><year>2013</year>. <article-title>The role of the podocyte in albumin
filtration</article-title>. <source><italic>Nat. Rev.
Nephrol.</italic></source><volume>9</volume>: <fpage>328</fpage>&#x2013;<lpage>336</lpage>.
doi: <pub-id pub-id-type="doi">10.1038/nrneph.2013.78</pub-id><pub-id pub-id-type="pmid">23609563</pub-id></mixed-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Cosgrove</surname><given-names>D.</given-names></name></person-group><year>2012</year>. <article-title>Glomerular pathology in Alport syndrome:
a molecular perspective</article-title>. <source><italic>Pediatr.
Nephrol.</italic></source><volume>27</volume>: <fpage>885</fpage>&#x2013;<lpage>890</lpage>.
doi: <pub-id pub-id-type="doi">10.1007/s00467-011-1868-z</pub-id><pub-id pub-id-type="pmid">21455721</pub-id></mixed-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Cosgrove</surname><given-names>D.</given-names></name><name><surname>Rodgers</surname><given-names>K.</given-names></name><name><surname>Meehan</surname><given-names>D.</given-names></name><name><surname>Miller</surname><given-names>C.</given-names></name><name><surname>Bovard</surname><given-names>K.</given-names></name><name><surname>Gilroy</surname><given-names>A.</given-names></name><name><surname>Gardner</surname><given-names>H.</given-names></name><name><surname>Kotelianski</surname><given-names>V.</given-names></name><name><surname>Gotwals</surname><given-names>P.</given-names></name><name><surname>Amatucci</surname><given-names>A.</given-names></name><name><surname>Kalluri</surname><given-names>R.</given-names></name></person-group><year>2000</year>. <article-title>Integrin alpha1beta1 and transforming
growth factor-beta1 play distinct roles in alport glomerular pathogenesis and serve as
dual targets for metabolic therapy</article-title>. <source><italic>Am. J.
Pathol.</italic></source><volume>157</volume>:
<fpage>1649</fpage>&#x2013;<lpage>1659</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0002-9440(10)64802-X</pub-id><pub-id pub-id-type="pmid">11073824</pub-id></mixed-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Gubler</surname><given-names>M. C.</given-names></name></person-group><year>2008</year>. <article-title>Inherited diseases of the glomerular
basement membrane</article-title>. <source><italic>Nat. Clin. Pract.
Nephrol.</italic></source><volume>4</volume>: <fpage>24</fpage>&#x2013;<lpage>37</lpage>. doi:
<pub-id pub-id-type="doi">10.1038/ncpneph0671</pub-id><pub-id pub-id-type="pmid">18094725</pub-id></mixed-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Hamano</surname><given-names>Y.</given-names></name><name><surname>Grunkemeyer</surname><given-names>J. A.</given-names></name><name><surname>Sudhakar</surname><given-names>A.</given-names></name><name><surname>Zeisberg</surname><given-names>M.</given-names></name><name><surname>Cosgrove</surname><given-names>D.</given-names></name><name><surname>Morello</surname><given-names>R.</given-names></name><name><surname>Lee</surname><given-names>B.</given-names></name><name><surname>Sugimoto</surname><given-names>H.</given-names></name><name><surname>Kalluri</surname><given-names>R.</given-names></name></person-group><year>2002</year>. <article-title>Determinants of vascular permeability in
the kidney glomerulus</article-title>. <source><italic>J. Biol.
Chem.</italic></source><volume>277</volume>: <fpage>31154</fpage>&#x2013;<lpage>31162</lpage>.
doi: <pub-id pub-id-type="doi">10.1074/jbc.M204806200</pub-id><pub-id pub-id-type="pmid">12039968</pub-id></mixed-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Harvey</surname><given-names>S. J.</given-names></name><name><surname>Zheng</surname><given-names>K.</given-names></name><name><surname>Jefferson</surname><given-names>B.</given-names></name><name><surname>Moak</surname><given-names>P.</given-names></name><name><surname>Sado</surname><given-names>Y.</given-names></name><name><surname>Naito</surname><given-names>I.</given-names></name><name><surname>Ninomiya</surname><given-names>Y.</given-names></name><name><surname>Jacobs</surname><given-names>R.</given-names></name><name><surname>Thorner</surname><given-names>P. S.</given-names></name></person-group><year>2003</year>. <article-title>Transfer of the &#x3B1;5(IV) Collagen Chain
Gene to Smooth Muscle Restores in Vivo Expression of the &#x3B1;6(IV) Collagen Chain in a
Canine Model of Alport Syndrome</article-title>. <source><italic>Am. J.
Pathol.</italic></source><volume>162</volume>: <fpage>873</fpage>&#x2013;<lpage>885</lpage>.
doi: <pub-id pub-id-type="doi">10.1016/S0002-9440(10)63883-7</pub-id><pub-id pub-id-type="pmid">12598321</pub-id></mixed-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Heidet</surname><given-names>L.</given-names></name><name><surname>Cai</surname><given-names>Y.</given-names></name><name><surname>Guicharnaud</surname><given-names>L.</given-names></name><name><surname>Antignac</surname><given-names>C.</given-names></name><name><surname>Gubler</surname><given-names>M. C.</given-names></name></person-group><year>2000</year>. <article-title>Glomerular expression of type IV collagen
chains in normal and X-linked Alport syndrome kidneys</article-title>.
<source><italic>Am. J. Pathol.</italic></source><volume>156</volume>:
<fpage>1901</fpage>&#x2013;<lpage>1910</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0002-9440(10)65063-8</pub-id><pub-id pub-id-type="pmid">10854213</pub-id></mixed-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Hudson</surname><given-names>B. G.</given-names></name><name><surname>Tryggvason</surname><given-names>K.</given-names></name><name><surname>Sundaramoorthy</surname><given-names>M.</given-names></name><name><surname>Neilson</surname><given-names>E. G.</given-names></name></person-group><year>2003</year>. <article-title>Alport&#x2019;s syndrome, Goodpasture&#x2019;s
syndrome, and type IV collagen</article-title>. <source><italic>N. Engl. J.
Med.</italic></source><volume>348</volume>: <fpage>2543</fpage>&#x2013;<lpage>2556</lpage>.
doi: <pub-id pub-id-type="doi">10.1056/NEJMra022296</pub-id><pub-id pub-id-type="pmid">12815141</pub-id></mixed-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Ichii</surname><given-names>O.</given-names></name><name><surname>Yabuki</surname><given-names>A.</given-names></name><name><surname>Sasaki</surname><given-names>N.</given-names></name><name><surname>Otsuka</surname><given-names>S.</given-names></name><name><surname>Ohta</surname><given-names>H.</given-names></name><name><surname>Yamasaki</surname><given-names>M.</given-names></name><name><surname>Takiguchi</surname><given-names>M.</given-names></name><name><surname>Namiki</surname><given-names>Y.</given-names></name><name><surname>Hashimoto</surname><given-names>Y.</given-names></name><name><surname>Endoh</surname><given-names>D.</given-names></name><name><surname>Kon</surname><given-names>Y.</given-names></name></person-group><year>2011</year>. <article-title>Pathological correlations between
podocyte injuries and renal functions in canine and feline chronic kidney
diseases</article-title>. <source><italic>Histol.
Histopathol.</italic></source><volume>26</volume>:
<fpage>1243</fpage>&#x2013;<lpage>1255</lpage>. <pub-id pub-id-type="pmid">21870328</pub-id></mixed-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Kashtan</surname><given-names>C. E.</given-names></name></person-group><year>2002</year>. <article-title>Animal models of Alport
syndrome</article-title>. <source><italic>Nephrol. Dial.
Transplant.</italic></source><volume>17</volume>:
<fpage>1359</fpage>&#x2013;<lpage>1362</lpage>. doi: <pub-id pub-id-type="doi">10.1093/ndt/17.8.1359</pub-id><pub-id pub-id-type="pmid">12147777</pub-id></mixed-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Kawachi</surname><given-names>H.</given-names></name><name><surname>Miyauchi</surname><given-names>N.</given-names></name><name><surname>Suzuki</surname><given-names>K.</given-names></name><name><surname>Han</surname><given-names>G. D.</given-names></name><name><surname>Orikasa</surname><given-names>M.</given-names></name><name><surname>Shimizu</surname><given-names>F.</given-names></name></person-group><year>2006</year>. <article-title>Role of podocyte slit diaphragm as a
filtration barrier (Review Article)</article-title>. <source><italic>Nephrology
(Carlton)</italic></source><volume>11</volume>: <fpage>274</fpage>&#x2013;<lpage>281</lpage>.
doi: <pub-id pub-id-type="doi">10.1111/j.1440-1797.2006.00583.x</pub-id><pub-id pub-id-type="pmid">16889564</pub-id></mixed-citation>
      </ref>
      <ref id="r13">
        <label>13</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Kobayashi</surname><given-names>R.</given-names></name><name><surname>Kamiie</surname><given-names>J.</given-names></name><name><surname>Yasuno</surname><given-names>K.</given-names></name><name><surname>Ogihara</surname><given-names>K.</given-names></name><name><surname>Shirota</surname><given-names>K.</given-names></name></person-group><year>2011</year>. <article-title>Expression of nephrin, podocin,
alpha-actinin-4 and alpha3-integrin in canine renal glomeruli</article-title>.
<source><italic>J. Comp. Pathol.</italic></source><volume>145</volume>:
<fpage>220</fpage>&#x2013;<lpage>225</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jcpa.2011.01.007</pub-id><pub-id pub-id-type="pmid">21388638</pub-id></mixed-citation>
      </ref>
      <ref id="r14">
        <label>14</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Lees</surname><given-names>G. E.</given-names></name></person-group><year>2013</year>. <article-title>Kidney diseases caused by glomerular
basement membrane type IV collagen defects in dogs</article-title>. <source><italic>J.
Vet. Emerg. Crit. Care (San Antonio)</italic></source><volume>23</volume>:
<fpage>184</fpage>&#x2013;<lpage>193</lpage>. doi: <pub-id pub-id-type="doi">10.1111/vec.12031</pub-id><pub-id pub-id-type="pmid">23464675</pub-id></mixed-citation>
      </ref>
      <ref id="r15">
        <label>15</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Lees</surname><given-names>G. E.</given-names></name><name><surname>Kashtan</surname><given-names>C. E.</given-names></name><name><surname>Michael</surname><given-names>A. F.</given-names></name><name><surname>Helman</surname><given-names>R. G.</given-names></name><name><surname>Naito</surname><given-names>I.</given-names></name><name><surname>Ninomiya</surname><given-names>Y.</given-names></name><name><surname>Sado</surname><given-names>Y.</given-names></name><name><surname>Kim</surname><given-names>Y.</given-names></name></person-group><year>2000</year>. <article-title>Expression of the alpha6 chain of type IV
collagen in glomerular basement membranes of healthy adult dogs</article-title>.
<source><italic>Am. J. Vet. Res.</italic></source><volume>61</volume>:
<fpage>38</fpage>&#x2013;<lpage>41</lpage>. doi: <pub-id pub-id-type="doi">10.2460/ajvr.2000.61.38</pub-id><pub-id pub-id-type="pmid">10630775</pub-id></mixed-citation>
      </ref>
      <ref id="r16">
        <label>16</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Lees</surname><given-names>G. E.</given-names></name><name><surname>Helman</surname><given-names>R. G.</given-names></name><name><surname>Kashtan</surname><given-names>C. E.</given-names></name><name><surname>Michael</surname><given-names>A. F.</given-names></name><name><surname>Homco</surname><given-names>L. D.</given-names></name><name><surname>Millichamp</surname><given-names>N. J.</given-names></name><name><surname>Ninomiya</surname><given-names>Y.</given-names></name><name><surname>Sado</surname><given-names>Y.</given-names></name><name><surname>Naito</surname><given-names>I.</given-names></name><name><surname>Kim</surname><given-names>Y.</given-names></name></person-group><year>1998</year>. <article-title>A model of autosomal recessive Alport
syndrome in English cocker spaniel dogs</article-title>. <source><italic>Kidney
Int.</italic></source><volume>54</volume>: <fpage>706</fpage>&#x2013;<lpage>719</lpage>. doi:
<pub-id pub-id-type="doi">10.1046/j.1523-1755.1998.00062.x</pub-id><pub-id pub-id-type="pmid">9734596</pub-id></mixed-citation>
      </ref>
      <ref id="r17">
        <label>17</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Lowe</surname><given-names>J. K.</given-names></name><name><surname>Guyon</surname><given-names>R.</given-names></name><name><surname>Cox</surname><given-names>M. L.</given-names></name><name><surname>Mitchell</surname><given-names>D. C.</given-names></name><name><surname>Lonkar</surname><given-names>A. L.</given-names></name><name><surname>Lingaas</surname><given-names>F.</given-names></name><name><surname>Andre</surname><given-names>C.</given-names></name><name><surname>Galibert</surname><given-names>F.</given-names></name><name><surname>Ostrander</surname><given-names>E. A.</given-names></name><name><surname>Murphy</surname><given-names>K. E.</given-names></name></person-group><year>2003</year>. <article-title>Radiation hybrid mapping of the canine
type I and type IV collagen gene subfamilies</article-title>. <source><italic>Funct.
Integr. Genomics</italic></source><volume>3</volume>:
<fpage>112</fpage>&#x2013;<lpage>116</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10142-003-0082-x</pub-id><pub-id pub-id-type="pmid">12687409</pub-id></mixed-citation>
      </ref>
      <ref id="r18">
        <label>18</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Myers</surname><given-names>J. C.</given-names></name><name><surname>Jones</surname><given-names>T. A.</given-names></name><name><surname>Pohjolainen</surname><given-names>E. R.</given-names></name><name><surname>Kadri</surname><given-names>A. S.</given-names></name><name><surname>Goddard</surname><given-names>A. D.</given-names></name><name><surname>Sheer</surname><given-names>D.</given-names></name><name><surname>Solomon</surname><given-names>E.</given-names></name><name><surname>Pihlajaniemi</surname><given-names>T.</given-names></name></person-group><year>1990</year>. <article-title>Molecular cloning of alpha 5(IV) collagen
and assignment of the gene to the region of the X chromosome containing the Alport
syndrome locus</article-title>. <source><italic>Am. J. Hum.
Genet.</italic></source><volume>46</volume>: <fpage>1024</fpage>&#x2013;<lpage>1033</lpage>.
<pub-id pub-id-type="pmid">2339699</pub-id></mixed-citation>
      </ref>
      <ref id="r19">
        <label>19</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Ninomiya</surname><given-names>Y.</given-names></name><name><surname>Kagawa</surname><given-names>M.</given-names></name><name><surname>Iyama</surname><given-names>K.</given-names></name><name><surname>Naito</surname><given-names>I.</given-names></name><name><surname>Kishiro</surname><given-names>Y.</given-names></name><name><surname>Seyer</surname><given-names>J. M.</given-names></name><name><surname>Sugimoto</surname><given-names>M.</given-names></name><name><surname>Oohashi</surname><given-names>T.</given-names></name><name><surname>Sado</surname><given-names>Y.</given-names></name></person-group><year>1995</year>. <article-title>Differential expression of two basement
membrane collagen genes, COL4A6 and COL4A5, demonstrated by immunofluorescence staining
using peptide-specific monoclonal antibodies</article-title>. <source><italic>J. Cell
Biol.</italic></source><volume>130</volume>: <fpage>1219</fpage>&#x2013;<lpage>1229</lpage>.
doi: <pub-id pub-id-type="doi">10.1083/jcb.130.5.1219</pub-id><pub-id pub-id-type="pmid">7657706</pub-id></mixed-citation>
      </ref>
      <ref id="r20">
        <label>20</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Nowend</surname><given-names>K. L.</given-names></name><name><surname>Starr-Moss</surname><given-names>A. N.</given-names></name><name><surname>Lees</surname><given-names>G. E.</given-names></name><name><surname>Berridge</surname><given-names>B. R.</given-names></name><name><surname>Clubb</surname><given-names>F. J.</given-names></name><name><surname>Kashtan</surname><given-names>C. E.</given-names></name><name><surname>Nabity</surname><given-names>M. B.</given-names></name><name><surname>Murphy</surname><given-names>K. E.</given-names></name></person-group><year>2012</year>. <article-title>Characterization of the genetic basis for
autosomal recessive hereditary nephropathy in the English Springer
Spaniel</article-title>. <source><italic>J. Vet. Intern.
Med.</italic></source><volume>26</volume>: <fpage>294</fpage>&#x2013;<lpage>301</lpage>. doi:
<pub-id pub-id-type="doi">10.1111/j.1939-1676.2012.00888.x</pub-id><pub-id pub-id-type="pmid">22369189</pub-id></mixed-citation>
      </ref>
      <ref id="r21">
        <label>21</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Pavenst&#xE4;dt</surname><given-names>H.</given-names></name><name><surname>Kriz</surname><given-names>W.</given-names></name><name><surname>Kretzler</surname><given-names>M.</given-names></name></person-group><year>2003</year>. <article-title>Cell biology of the glomerular
podocyte</article-title>. <source><italic>Physiol.
Rev.</italic></source><volume>83</volume>: <fpage>253</fpage>&#x2013;<lpage>307</lpage>. doi:
<pub-id pub-id-type="doi">10.1152/physrev.00020.2002</pub-id><pub-id pub-id-type="pmid">12506131</pub-id></mixed-citation>
      </ref>
      <ref id="r22">
        <label>22</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Peissel</surname><given-names>B.</given-names></name><name><surname>Geng</surname><given-names>L.</given-names></name><name><surname>Kalluri</surname><given-names>R.</given-names></name><name><surname>Kashtan</surname><given-names>C.</given-names></name><name><surname>Rennke</surname><given-names>H. G.</given-names></name><name><surname>Gallo</surname><given-names>G. R.</given-names></name><name><surname>Yoshioka</surname><given-names>K.</given-names></name><name><surname>Sun</surname><given-names>M. J.</given-names></name><name><surname>Hudson</surname><given-names>B. G.</given-names></name><name><surname>Neilson</surname><given-names>E. G.</given-names></name></person-group><year>1995</year>. <article-title>Comparative distribution of the alpha
1(IV), alpha 5(IV), and alpha 6(IV) collagen chains in normal human adult and fetal
tissues and in kidneys from X-linked Alport syndrome patients</article-title>.
<source><italic>J. Clin. Invest.</italic></source><volume>96</volume>:
<fpage>1948</fpage>&#x2013;<lpage>1957</lpage>. doi: <pub-id pub-id-type="doi">10.1172/JCI118241</pub-id><pub-id pub-id-type="pmid">7560087</pub-id></mixed-citation>
      </ref>
      <ref id="r23">
        <label>23</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Ryu</surname><given-names>M.</given-names></name><name><surname>Mulay</surname><given-names>S. R.</given-names></name><name><surname>Miosge</surname><given-names>N.</given-names></name><name><surname>Gross</surname><given-names>O.</given-names></name><name><surname>Anders</surname><given-names>H. J.</given-names></name></person-group><year>2012</year>. <article-title>Tumour necrosis factor-alpha drives
Alport glomerulosclerosis in mice by promoting podocyte apoptosis</article-title>.
<source><italic>J. Pathol.</italic></source><volume>226</volume>:
<fpage>120</fpage>&#x2013;<lpage>131</lpage>. doi: <pub-id pub-id-type="doi">10.1002/path.2979</pub-id><pub-id pub-id-type="pmid">21953121</pub-id></mixed-citation>
      </ref>
      <ref id="r24">
        <label>24</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Sado</surname><given-names>Y.</given-names></name><name><surname>Kagawa</surname><given-names>M.</given-names></name><name><surname>Kishiro</surname><given-names>Y.</given-names></name><name><surname>Sugihara</surname><given-names>K.</given-names></name><name><surname>Naito</surname><given-names>I.</given-names></name><name><surname>Seyer</surname><given-names>J. M.</given-names></name><name><surname>Sugimoto</surname><given-names>M.</given-names></name><name><surname>Oohashi</surname><given-names>T.</given-names></name><name><surname>Ninomiya</surname><given-names>Y.</given-names></name></person-group><year>1995</year>. <article-title>Establishment by the rat lymph node
method of epitope-defined monoclonal antibodies recognizing the six different alpha
chains of human type IV collagen</article-title>. <source><italic>Histochem. Cell
Biol.</italic></source><volume>104</volume>: <fpage>267</fpage>&#x2013;<lpage>275</lpage>.
doi: <pub-id pub-id-type="doi">10.1007/BF01464322</pub-id><pub-id pub-id-type="pmid">8548560</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
